We are live on
!
Find out more
Denali Therapeutics
DNLI
DNLI
200 hedge funds and large institutions have $2.84B invested in Denali Therapeutics in 2022 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 79 increasing their positions, 55 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
503% more call options, than puts
Call options by funds: $3.05M | Put options by funds: $506K
68% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 19
44% more repeat investments, than reductions
Existing positions increased: 79 | Existing positions reduced: 55
6% more funds holding
Funds holding: 188 → 200 (+12)
4% more capital invested
Capital invested by funds: $2.73B → $2.84B (+$109M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0.44% less ownership
Funds ownership: 75.39% → 74.95% (-0.44%)
Holders
200
Holders Change
+12
Holders Change %
+6.38%
% of All Funds
3.45%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
32
Increased
79
Reduced
55
Closed
19
Calls
$3.05M
Puts
$506K
Net Calls
+$2.54M
Net Calls Change
+$1.29M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$20.6M |
| 2 |
State Street
Boston,
Massachusetts
|
+$14.4M |
| 3 |
Goldman Sachs
New York
|
+$10M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
+$9.04M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$8.56M |
Top Sellers
| 1 |
AVM
Arch Venture Management
Chicago,
Illinois
|
-$48.8M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$36.8M |
| 3 |
CC
Casdin Capital
New York
|
-$16.4M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.6M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$11.3M |
